Skip to main content

ASCVD

2
Pipeline Programs
4
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

RNA Therapeutic
1100%
+ 3 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Daewon Pharma
Daewon PharmaKorea - Hwaseong
1 program
1
Combination therapyPhase 41 trial
Active Trials
NCT06767774Recruiting2,000Est. Jan 2030
Sandoz
SandozAustria - Kundl
1 program
1
Inclisiran SodiumPhase 3RNA Therapeutic
Amgen
AmgenTHOUSAND OAKS, CA
1 program
Care Champion InterventionN/A1 trial
Active Trials
NCT06471036Recruiting400Est. Feb 2027
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
Our Practice AdvisoryN/A1 trial
Active Trials
NCT07868809Not Yet Recruiting20Est. Feb 2028

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
Daewon PharmaCombination therapy
Merck & Co.Our Practice Advisory
AmgenCare Champion Intervention

Clinical Trials (3)

Total enrollment: 2,420 patients across 3 trials

NCT06767774Daewon PharmaCombination therapy

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

Start: Apr 2025Est. completion: Jan 20302,000 patients
Phase 4Recruiting
NCT07868809Merck & Co.Our Practice Advisory

Coronary Artery Calcium (CAC) Testing in Primary Care

Start: Feb 2027Est. completion: Feb 202820 patients
N/ANot Yet Recruiting
NCT06471036AmgenCare Champion Intervention

Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?

Start: Oct 2024Est. completion: Feb 2027400 patients
N/ARecruiting

Related Jobs

Senior Director, Clinical Science, Atherosclerosis

Merck & Co.Merck & Co.
USA - New Jersey - Rahway; USA - Massachusetts - Boston (MA Parcel B Laboratory); ARG - Argentina - Argentina; USA - Pennsylvania - Upper Gwynedd; USA - California - San Francisco (Not Applicable)
2w ago
$210K - $331K/yr

Associate Director, Study Manager - Atherosclerosis and Metabolism

Merck & Co.Merck & Co.
USA - New Jersey - Rahway; USA - Pennsylvania - Upper Gwynedd (Not Applicable)
2w ago
$142K - $224K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
2 actively recruiting trials targeting 2,420 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.